Figure 3
Figure 3. Association of HLA-DRB1 and HLA-DQB1 alleles with asparaginase hypersensitivity. Using a general linear model adjusted for gender, age, treatment arm, and ALL immunophenotype, (A) HLA-DRB1*07:01 (P = .001 [Padjusted = .023]) was associated with asparaginase hypersensitivities within the discovery cohort (n = 541). The dashed horizontal red line identifies a permuted significance threshold of P < .05 that is adjusted for multiple testing. Patients with the HLA-DRB1*07:01 allele had a higher incidence of hypersensitivity compared with patients that did not have the allele within the (B) discovery cohort (n = 541), (C) validation cohort (n = 1329), and (D) the combined cohort (n = 1870).

Association of HLA-DRB1 and HLA-DQB1 alleles with asparaginase hypersensitivity. Using a general linear model adjusted for gender, age, treatment arm, and ALL immunophenotype, (A) HLA-DRB1*07:01 (P = .001 [Padjusted = .023]) was associated with asparaginase hypersensitivities within the discovery cohort (n = 541). The dashed horizontal red line identifies a permuted significance threshold of P < .05 that is adjusted for multiple testing. Patients with the HLA-DRB1*07:01 allele had a higher incidence of hypersensitivity compared with patients that did not have the allele within the (B) discovery cohort (n = 541), (C) validation cohort (n = 1329), and (D) the combined cohort (n = 1870).

Close Modal

or Create an Account

Close Modal
Close Modal